Leap Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q2 2024 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q3 2024 | 3 | -$0.42 | -$0.37 | -$0.40 |
| Q1 2025 | 2 | -$0.40 | -$0.33 | -$0.36 |
| Q2 2025 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q3 2025 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q4 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
Leap Therapeutics, Inc. Earnings Date And Information
Leap Therapeutics, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.44 earnings per share for the quarter, topping analysts' consensus estimates of $-0.46 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Leap Therapeutics, Inc. has generated $-4 earnings per share over the last year ($-3.98 diluted earnings per share) and currently has a price-to-earnings ratio of -1.65. Leap Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Leap Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.46 | -$0.44 | 0.02 | $0 | $0 |
| 08/12/2024 | Q2 2024 | -$0.42 | -$0.51 | -0.09 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$0.57 | -$0.51 | 0.06 | $0 | |
| 03/18/2024 | Q4 2023 | -$0.56 | -$0.46 | 0.1 | $634,000 | |
| 11/13/2023 | Q3 2023 | -$0.48 | -$0.51 | -0.03 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.98 | -$0.91 | 0.07 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.90 | -$3.17 | -2.27 | $0 | |
| 03/24/2023 | Q4 2022 | -$0.90 | -$1.07 | -0.17 | $0 | |
| 11/14/2022 | Q3 2022 | -$1.10 | -$1.40 | -0.3 | $0 | |
| 08/12/2022 | Q2 2022 | -$1.00 | -$1.57 | -0.57 | $0 | |
| 05/13/2022 | Q1 2022 | -$1.10 | -$0.90 | 0.2 | $0 | |
| 03/11/2022 | Q4 2021 | -$1.10 | -$0.95 | 0.15 | $375,000 | |
| 11/12/2021 | Q3 2021 | -$1.10 | -$1.42 | -0.32 | $1.44 M | $375,000 |
| 08/13/2021 | Q2 2021 | -$1.30 | -$1.25 | 0.05 | $305,000 | $375,000 |
| 05/14/2021 | Q1 2021 | -$1.10 | -$1.20 | -0.1 | $375,000 | |
| 03/12/2021 | Q4 2020 | -$0.80 | -$0.88 | -0.08 | $375,000 | |
| 11/12/2020 | Q3 2020 | -$1.20 | -$0.92 | 0.28 | $200,000 | $375,000 |
| 08/13/2020 | Q2 2020 | -$1.70 | -$1.24 | 0.46 | $1.30 M | $375,000 |
| 05/14/2020 | Q1 2020 | -$2.60 | -$2.29 | 0.31 | $375,000 | |
| 03/16/2020 | Q4 2019 | -$3.20 | -$3.30 | -0.1 | $0 |
Leap Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Leap Therapeutics, Inc.'s earnings date?
Leap Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
-
Did Leap Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Leap Therapeutics, Inc. (:LPTX) reported $-0.44 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.46 by $0.02.
-
How can I listen to Leap Therapeutics, Inc.'s earnings conference call?
The conference call for Leap Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Leap Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Leap Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Leap Therapeutics, Inc. generate each year?
Leap Therapeutics, Inc. (:LPTX) has a recorded net income of $0. Leap Therapeutics, Inc. has generated $-3.98 earnings per share over the last four quarters.
-
What is Leap Therapeutics, Inc.'s price-to-earnings ratio?
Leap Therapeutics, Inc. (:LPTX) has a price-to-earnings ratio of -1.65 and price/earnings-to-growth ratio is -0.47.
